Hepatitis C virus infection among Alaskan drug users. 1997

D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000413 Alaska State of the UNITED STATES OF AMERICA bounded on the east by Canada and on the north, west, and south by the Pacific Ocean and the Bering Sea. Aleutian Islands
D015819 Substance Abuse, Intravenous Abuse, overuse, or misuse of a substance by its injection into a vein. Drug Abuse, Intravenous,Drug Abuse, Parenteral,Intravenous Drug Abuse,Intravenous Substance Abuse,Parenteral Drug Abuse
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
May 2008, BMC infectious diseases,
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
June 1995, Journal of hepatology,
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
August 1997, Addiction (Abingdon, England),
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
August 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
August 1993, The Medical journal of Australia,
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
July 2003, Journal of medical virology,
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
December 1997, Journal of epidemiology and community health,
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
October 1996, The Journal of infectious diseases,
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
June 1997, Virus research,
D G Fisher, and A M Fenaughty, and A A Paschane, and D M Paschane, and H H Cagle, and S M Orr
January 2014, PloS one,
Copied contents to your clipboard!